Report Detail
(Post-pandemic Era)-Global Rapid Antigen Testing Market Segment Research Report 2022
- RnM4477313 |
- 04 August, 2022 |
- Global |
- 106 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Rapid Antigen Testing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Rapid Antigen Testing industry at home and abroad, estimate the overall market scale of the Rapid Antigen Testing industry and the market share of major countries, Rapid Antigen Testing industry, and study and judge the downstream market demand of Rapid Antigen Testing through systematic research, Analyze the competition pattern of Rapid Antigen Testing, so as to help solve the pain points of various stakeholders in Rapid Antigen Testing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Rapid Antigen Testing Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Rapid Antigen Testing Market?
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Major Type of Rapid Antigen Testing Covered in XYZResearch report:
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio
Application Segments Covered in XYZResearch Market
Hospitals
Specialty Clinics
Diagnostic Centers
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Rapid Antigen Testing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Rapid Antigen Testing Market by Value
- 2.2.1 Global Rapid Antigen Testing Revenue by Type
- 2.2.2 Global Rapid Antigen Testing Market by Value (%)
- 2.3 Global Rapid Antigen Testing Market by Production
- 2.3.1 Global Rapid Antigen Testing Production by Type
- 2.3.2 Global Rapid Antigen Testing Market by Production (%)
3. The Major Driver of Rapid Antigen Testing Industry
- 3.1 Historical & Forecast Global Rapid Antigen Testing Demand
- 3.2 Largest Application for Rapid Antigen Testing (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Rapid Antigen Testing Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Rapid Antigen Testing Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Rapid Antigen Testing Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Rapid Antigen Testing Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Rapid Antigen Testing Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Rapid Antigen Testing Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Rapid Antigen Testing Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Rapid Antigen Testing Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Rapid Antigen Testing Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Rapid Antigen Testing Average Price Trend
- 12.1 Market Price for Each Type of Rapid Antigen Testing in US (2018-2022)
- 12.2 Market Price for Each Type of Rapid Antigen Testing in Europe (2018-2022)
- 12.3 Market Price for Each Type of Rapid Antigen Testing in China (2018-2022)
- 12.4 Market Price for Each Type of Rapid Antigen Testing in Japan (2018-2022)
- 12.5 Market Price for Each Type of Rapid Antigen Testing in India (2018-2022)
- 12.6 Market Price for Each Type of Rapid Antigen Testing in Korea (2018-2022)
- 12.7 Market Price for Each Type of Rapid Antigen Testing in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Rapid Antigen Testing Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Rapid Antigen Testing
14. Rapid Antigen Testing Competitive Landscape
- 14.1 Abbott Laboratories
- 14.1.1 Abbott Laboratories Company Profiles
- 14.1.2 Abbott Laboratories Product Introduction
- 14.1.3 Abbott Laboratories Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 F. Hoffmann-La Roche
- 14.2.1 F. Hoffmann-La Roche Company Profiles
- 14.2.2 F. Hoffmann-La Roche Product Introduction
- 14.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Oxford BioMedica
- 14.3.1 Oxford BioMedica Company Profiles
- 14.3.2 Oxford BioMedica Product Introduction
- 14.3.3 Oxford BioMedica Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Affinity Biologicals
- 14.4.1 Affinity Biologicals Company Profiles
- 14.4.2 Affinity Biologicals Product Introduction
- 14.4.3 Affinity Biologicals Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Epitope Diagnostics
- 14.5.1 Epitope Diagnostics Company Profiles
- 14.5.2 Epitope Diagnostics Product Introduction
- 14.5.3 Epitope Diagnostics Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Sino Biological
- 14.6.1 Sino Biological Company Profiles
- 14.6.2 Sino Biological Product Introduction
- 14.6.3 Sino Biological Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 R-Biopharma
- 14.7.1 R-Biopharma Company Profiles
- 14.7.2 R-Biopharma Product Introduction
- 14.7.3 R-Biopharma Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Cell Biolabs
- 14.8.1 Cell Biolabs Company Profiles
- 14.8.2 Cell Biolabs Product Introduction
- 14.8.3 Cell Biolabs Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Thermo Fisher Scientific
- 14.9.1 Thermo Fisher Scientific Company Profiles
- 14.9.2 Thermo Fisher Scientific Product Introduction
- 14.9.3 Thermo Fisher Scientific Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Bio-Rad Laboratories
- 14.10.1 Bio-Rad Laboratories Company Profiles
- 14.10.2 Bio-Rad Laboratories Product Introduction
- 14.10.3 Bio-Rad Laboratories Rapid Antigen Testing Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Rapid Antigen Testing. Industry analysis & Market Report on Rapid Antigen Testing is a syndicated market report, published as (Post-pandemic Era)-Global Rapid Antigen Testing Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Rapid Antigen Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
